the problem
There is a scarcity of cost-effectiveness understanding of evidence-based pathways, due in part to studies failing to incorporate Quality of Life (QoL) measures, PREMs (patient reported experience measures) and PROMs (patient reported outcomes measures), lack of population-based data and limited use of sophisticated health economic evaluations.
the solution
This strategy will inform decision making around comparative value for money by evaluating evidence-based pathways, policy changes, and socioeconomic inequalities.
our aims
-
Evaluate costs, outcomes and cost-effectiveness of evidence based versus non-evidence-based pathways to care
-
Independently assess the effects of health policy and practice changes at state and national levels on individuals with eating disorders accessing care including uptake of Medicare items for eating disorders
-
Evaluate the changing inequalities in access and receipt of care over time and disentangle to identify driving factors
“Our research focuses on evaluating the costs, health outcomes, cost-effectiveness, and equity concerns of health interventions for the prevention or treatment of chronic conditions amongst children and adolescents, adults, and older people as well as inter-generational impacts.”
Dr Michelle Cunich, Research Lead, Sydney Health Economics Collaborative
Development of health system and economic models that evaluate current and future interventions in relation to outcomes, cost-effectiveness, and equity of access.